Literature DB >> 32897449

Critical appraisal of tobacco dependence treatment guidelines.

Maguy Saffouh El Hajj1, Myriam Jaam2, Saba Abdal Salam Sheikh Ali3, Rana Saleh2, Ahmed Awaisu2, Bridget Paravattil2, Kyle John Wilby4.   

Abstract

Background Tobacco use is a leading preventable cause of morbidity and mortality globally. Clinical practice guidelines for the treatment of tobacco use dependence are of varied scope and quality, making it challenging for users to select and apply recommendations. Objective The study objective is to identify and critically appraise the quality of existing clinical practice guidelines for tobacco cessation. Setting The study occurred between collaborative academic institutions located in Qatar and New Zealand. Methods A systematic literature search was performed for the period 2006-2018 through the following databases: PubMed, EMBASE, CINAHL, ISI Web of Science, Scopus, National Guideline Clearing House, Campbell Library, Health System Evidence, Joanna Briggs Institute Evidence-Based Practice Database, Academic Search Complete, ProQuest, PROSPERO, and Google Scholar. Relevant professional societies' and health agencies' websites were also searched. Two reviewers independently extracted and assessed guidelines' quality using Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Main outcome measure Standardized domain scores according to the AGREE II instrument. Results 7741 hits were identified. After removing duplicates and screening, 24 guidelines were included. Highest guideline quality was for National Institute for Health and Care Excellence (NICE) guideline with an overall ranking score of 87.56% and least quality was for Japanese Circulation Society Joint Working Group with an overall score of 29.34%. Domain 4 of AGREE II (clarity of presentation) had the highest average quality score (70.95%), while the lowest average quality scores were for Domain 2 (Rigour of Development) (50.21%) and Domain 5 (Applicability) (45.05%). Conclusion Seven guidelines were judged to be of high quality (overall score of ≥ 70%). Future guidelines for tobacco dependence treatment should use rigorous methods of development and provide applicable recommendations.

Entities:  

Keywords:  AGREE II; Critical appraisal; Guideline; Smoking cessation; Tobacco cessation

Year:  2020        PMID: 32897449      PMCID: PMC7878272          DOI: 10.1007/s11096-020-01110-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  29 in total

1.  Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization.

Authors:  Richard N Shiffman; Paul Shekelle; J Marc Overhage; Jean Slutsky; Jeremy Grimshaw; Aniruddha M Deshpande
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

Review 2.  Guidelines for Smoking Cessation (JCS 2010)--digest version.

Authors: 
Journal:  Circ J       Date:  2012-02-11       Impact factor: 2.993

3.  Rigorous method to assess quality and generalizability of clinical practice guidelines.

Authors:  Ahmed Ali Farghali; Raja Al-Khawaja; Lama Madi; Ahmed Elbardissy; Hesham Mahmoud Hamdy; Kyle J Wilby
Journal:  Can J Hosp Pharm       Date:  2014-09

4.  The quality of clinical practice guidelines for chronic respiratory diseases and the reliability of the AGREE II: an observational study.

Authors:  Juliana Souza Uzeloto; Anne M Moseley; Mark R Elkins; Marcia Rodrigues Franco; Rafael Zambelli Pinto; Ana Paula Coelho Figueira Freire; Ercy Mara Cipulo Ramos
Journal:  Physiotherapy       Date:  2016-11-15       Impact factor: 3.358

5.  Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Peter G Shields; Roy S Herbst; Douglas Arenberg; Neal L Benowitz; Laura Bierut; Julie Bylund Luckart; Paul Cinciripini; Bradley Collins; Sean David; James Davis; Brian Hitsman; Andrew Hyland; Margaret Lang; Scott Leischow; Elyse R Park; W Thomas Purcell; Jill Selzle; Andrea Silber; Sharon Spencer; Tawee Tanvetyanon; Brian Tiep; Hilary A Tindle; Reginald Tucker-Seeley; James Urbanic; Monica Webb Hooper; Benny Weksler; C Will Whitlock; Douglas E Wood; Jennifer Burns; Jillian Scavone
Journal:  J Natl Compr Canc Netw       Date:  2016-11       Impact factor: 11.908

6.  Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2017-04-05       Impact factor: 79.321

Review 7.  Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.

Authors:  Carrie D Patnode; Jillian T Henderson; Jamie H Thompson; Caitlyn A Senger; Stephen P Fortmann; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2015-09-22       Impact factor: 25.391

Review 8.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

Review 9.  Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Authors:  Kate Cahill; Sarah Stevens; Rafael Perera; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

10.  A patient-centred approach to health service delivery: improving health outcomes for people with chronic illness.

Authors:  Masoud Mirzaei; Clive Aspin; Beverley Essue; Yun-Hee Jeon; Paul Dugdale; Tim Usherwood; Stephen Leeder
Journal:  BMC Health Serv Res       Date:  2013-07-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.